Actuate Therapeutics, Inc.
ACTU
$2.15
-$0.12-5.29%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 13.16M | 16.92M | 6.49M | 3.89M | 8.64M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 484.00K | 519.20K | 195.90K | 359.20K | 566.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.64M | 17.44M | 6.69M | 4.25M | 9.21M |
|
|
|||||
| Total Current Assets | 13.64M | 17.44M | 6.69M | 4.25M | 9.21M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 392.50K | 269.90K | 280.30K | 234.50K | 110.50K |
| Total Assets | 14.04M | 17.71M | 6.97M | 4.48M | 9.32M |
|
|
|||||
| Total Accounts Payable | 1.52M | 1.25M | 3.17M | 2.64M | 1.92M |
| Total Accrued Expenses | 4.18M | 5.13M | 6.03M | 6.51M | 6.88M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 5.71M | 6.37M | 9.20M | 9.15M | 8.80M |
|
|
|||||
| Total Current Liabilities | 5.71M | 6.37M | 9.20M | 9.15M | 8.80M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 405.00K | 405.00K | 421.90K | 416.80K | 411.80K |
| Total Liabilities | 6.11M | 6.78M | 9.62M | 9.57M | 9.21M |
|
|
|||||
| Common Stock & APIC | 162.53M | 160.99M | 141.99M | 133.61M | 132.48M |
| Retained Earnings | -154.61M | -150.05M | -144.65M | -138.70M | -132.38M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 7.92M | 10.94M | -2.65M | -5.09M | 104.20K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 7.92M | 10.94M | -2.65M | -5.09M | 104.20K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 7.92M | 10.94M | -2.65M | -5.09M | 104.20K |
|
|
|||||